Imaging biomarkers of impairing brain injuries identified in athletes

Combining structural MRI, diffusion-weighted MRI and multivariate analysis, researchers at Cleveland Clinic’s Lou Ruvo Center for Brain Health in Las Vegas have identified seven biomarkers of early brain damage related to cognitive decline in athletes who’ve taken a lot of blows to the head.   

RSNA’s Radiology published the study online July 25.

The biomarkers—changes in brain-matter volume, thickness and organization—showed up in the forceps major, left inferior longitudinal fasciculus, left cerebellum, right cortex, left thalamus, right pallidum and right rostral anterior cingulate cortex.

The study subjects were professional boxers and mixed martial artists participating in the Ruvo organization’s ongoing Professional Fighters Brain Health Study.

Virendra Mishra, PhD, and colleagues included 91 neuropsychologically impaired fighters, 182 nonimpaired fighters and 20 control participants who never competed in contact sports in their main baseline analysis.

In a follow-up analysis, they looked at 17 impaired fighters, 39 nonimpaired fighters and six controls.

Along with the seven biomarkers, the researchers found significant associations between imaging signatures of damage and years of fighting, psychomotor speed and number of fights.

In their discussion, Mishra et al note that, unlike authors of previous studies, they identified structures associated with cognition without any regional a priori bias.

“Post hoc analysis of these features at baseline not only showed significant group differences but also showed a differential association with clinical scores and exposure to fighting at an individual level, suggesting that these features are characteristic of an imaging biomarker,” they write. “Moreover, the imaging biomarkers allowed successful differentiation of cognitively impaired fighters from nonimpaired fighters at follow-up, which suggests that the combination of these imaging biomarkers may provide quantifiable and objective information about the progression of cognitive decline due to repeated head trauma.”

RSNA has posted the study in full for free.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.